Lindora acquires new fleet of Zerona Z6 body contouring machines

Lindora, a US weight loss and wellness company said that it has acquired a new fleet of Zerona Z6 body contouring machines for an undisclosed price to expand its body contouring services on the west coast.

Developed by Erchonia, Zerona Z6 body contouring technology is said to be a full-body fat loss treatment that utilizes low-level, cold laser technology to remove excess fat around a person’s waist, hips, thighs, chest, arms, neck, and ankles.

Zerona is claimed to be the first and only non-invasive laser that has been cleared by the FDA for over-the-counter use.

Will Righeimer – CEO of Lindora said: “This acquisition of new Zerona Z6 machines means that we can continue to broaden our wellness service offering to our patients, giving them more tools to help them on their journey to becoming healthier and looking and feeling their best.”

See also  Microsoft and NVIDIA forge ahead with AI and cloud computing in healthcare
Dr. Amy Lee using the new Zerona Z6 body contouring technology to a Lindora Clinic patient
Dr. Amy Lee using the new Zerona Z6 body contouring technology to a Lindora Clinic patient. Photo courtesy of Business Wire.

Lindora plans to offer Zerona Z6 body contouring services in most of its 34 clinics across Southern California.

Dr. Amy Lee, Chief Medical Officer at Lindora said: “The first is that patients can see a real difference in their appearance in about six treatments,” said Lee. In a clinical study conducted by Zerona, patients lost an average of 6.22 total inches over the combined measurement areas when completing six sessions.

See also  AstraZeneca secures FDA approval for Lumoxiti in hairy cell leukemia treatment

“The second is that patients prefer Zerona because there is no pain, bruising, or downtime for recovery which can sometimes be the case with some other popular body sculpting services.”

Established in 1971, Lindora was acquired by private equity firm Solis Capital Partners and venture capital company Innovate Partners a few years ago. A new leadership team was formed shortly after the change in ownership and the business is said to have been evolving rapidly since then to address the needs of its patients and a US population whose obesity problem is at epidemic proportions.

See also  Aspirin no longer recommended for preventing heart attack or stroke in older adults

Discover more from Business-News-Today.com

Subscribe to get the latest posts sent to your email.